Logo image of JKS

JINKOSOLAR HOLDING CO-ADR (JKS) Stock Fundamental Analysis

USA - NYSE:JKS - US47759T1007 - ADR

24.09 USD
-1.25 (-4.93%)
Last: 9/18/2025, 8:04:00 PM
24.79 USD
+0.7 (+2.91%)
Pre-Market: 9/19/2025, 5:22:50 AM
Fundamental Rating

3

JKS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. JKS has a bad profitability rating. Also its financial health evaluation is rather negative. JKS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year JKS was profitable.
JKS had positive earnings in each of the past 5 years.
JKS had a positive operating cash flow in 4 of the past 5 years.
JKS Yearly Net Income VS EBIT VS OCF VS FCFJKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

JKS has a Return On Assets (-1.53%) which is in line with its industry peers.
JKS's Return On Equity of -10.18% is on the low side compared to the rest of the industry. JKS is outperformed by 66.96% of its industry peers.
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROIC N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
JKS Yearly ROA, ROE, ROICJKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

JKS's Profit Margin has declined in the last couple of years.
JKS has a Gross Margin of 8.39%. This is amonst the worse of the industry: JKS underperforms 89.29% of its industry peers.
JKS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for JKS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
JKS Yearly Profit, Operating, Gross MarginsJKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. Health

2.1 Basic Checks

JKS does not have a ROIC to compare to the WACC, probably because it is not profitable.
JKS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for JKS has been increased compared to 5 years ago.
The debt/assets ratio for JKS is higher compared to a year ago.
JKS Yearly Shares OutstandingJKS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JKS Yearly Total Debt VS Total AssetsJKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

JKS has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
JKS's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. JKS is outperformed by 93.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC2.39%
JKS Yearly LT Debt VS Equity VS FCFJKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

2.3 Liquidity

JKS has a Current Ratio of 1.33. This is a normal value and indicates that JKS is financially healthy and should not expect problems in meeting its short term obligations.
JKS's Current ratio of 1.33 is on the low side compared to the rest of the industry. JKS is outperformed by 86.61% of its industry peers.
JKS has a Quick Ratio of 1.07. This is a normal value and indicates that JKS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.07, JKS is doing worse than 86.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.07
JKS Yearly Current Assets VS Current LiabilitesJKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

5

3. Growth

3.1 Past

JKS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.77%.
JKS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.87% yearly.
The Revenue for JKS has decreased by -29.85% in the past year. This is quite bad
JKS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.40% yearly.
EPS 1Y (TTM)-99.77%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-464.91%
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%-40.23%

3.2 Future

Based on estimates for the next years, JKS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.24% on average per year.
The Revenue is expected to grow by 5.54% on average over the next years.
EPS Next Y-339.75%
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
EPS Next 5YN/A
Revenue Next Year-24.38%
Revenue Next 2Y-0.39%
Revenue Next 3Y5.54%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JKS Yearly Revenue VS EstimatesJKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B 100B
JKS Yearly EPS VS EstimatesJKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1204.50, which means the current valuation is very expensive for JKS.
Compared to the rest of the industry, the Price/Earnings ratio of JKS indicates a slightly more expensive valuation: JKS is more expensive than 61.61% of the companies listed in the same industry.
JKS is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 17.25, which indicates a rather expensive current valuation of JKS.
Based on the Price/Forward Earnings ratio, JKS is valued cheaper than 83.93% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. JKS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 1204.5
Fwd PE 17.25
JKS Price Earnings VS Forward Price EarningsJKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800 1K

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JKS is valued a bit cheaper than 76.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.63
JKS Per share dataJKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

A more expensive valuation may be justified as JKS's earnings are expected to grow with 41.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.67%
EPS Next 3Y41.24%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.69%, JKS is a good candidate for dividend investing.
JKS's Dividend Yield is rather good when compared to the industry average which is at 2.31. JKS pays more dividend than 100.00% of the companies in the same industry.
JKS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 11.69%

5.2 History

JKS has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
JKS Yearly Dividends per shareJKS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1

5.3 Sustainability

DPN/A
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
JKS Yearly Income VS Free CF VS DividendJKS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

JINKOSOLAR HOLDING CO-ADR

NYSE:JKS (9/18/2025, 8:04:00 PM)

Premarket: 24.79 +0.7 (+2.91%)

24.09

-1.25 (-4.93%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-28 2025-08-28/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners31.58%
Inst Owner Change-0.61%
Ins Owners4.9%
Ins Owner ChangeN/A
Market Cap1.24B
Analysts50.77
Price Target24.79 (2.91%)
Short Float %35.38%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield 11.69%
Yearly Dividend1.48
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-Date07-02 2025-07-02 (1.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)146.1%
Min EPS beat(2)-49.23%
Max EPS beat(2)341.42%
EPS beat(4)3
Avg EPS beat(4)228.1%
Min EPS beat(4)-49.23%
Max EPS beat(4)488.11%
EPS beat(8)6
Avg EPS beat(8)159.23%
EPS beat(12)8
Avg EPS beat(12)116.31%
EPS beat(16)10
Avg EPS beat(16)129.53%
Revenue beat(2)0
Avg Revenue beat(2)-86.85%
Min Revenue beat(2)-87.8%
Max Revenue beat(2)-85.9%
Revenue beat(4)0
Avg Revenue beat(4)-86.68%
Min Revenue beat(4)-88.21%
Max Revenue beat(4)-84.79%
Revenue beat(8)0
Avg Revenue beat(8)-86.08%
Revenue beat(12)3
Avg Revenue beat(12)-54.37%
Revenue beat(16)4
Avg Revenue beat(16)-42.05%
PT rev (1m)0%
PT rev (3m)1.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.48%
EPS NY rev (1m)-16.68%
EPS NY rev (3m)-5.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.74%
Valuation
Industry RankSector Rank
PE 1204.5
Fwd PE 17.25
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB 0.55
EV/EBITDA 16.63
EPS(TTM)0.02
EY0.08%
EPS(NY)1.4
Fwd EY5.8%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS226.3
BVpS50.14
TBVpS43.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.39%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Debt/EBITDA 10.8
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.07
Altman-Z N/A
F-ScoreN/A
WACC2.39%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.77%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-464.91%
EPS Next Y-339.75%
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%-40.23%
Revenue Next Year-24.38%
Revenue Next 2Y-0.39%
Revenue Next 3Y5.54%
Revenue Next 5YN/A
EBIT growth 1Y-189.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year204.26%
EBIT Next 3Y124.49%
EBIT Next 5YN/A
FCF growth 1Y-45.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.87%
OCF growth 3Y239.49%
OCF growth 5Y64.22%